• 13 Citations
  • 1 h-Index
20162019
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Area of Expertise

Dr. Gaviola is a critical care pharmacist who focuses her research on risk factors related to medication dosing in the intensive care unit and adverse effects related to use of certain medication combinations.

Education/Academic qualification

PharmD, University of Rhode Island

Fingerprint Dive into the research topics where Marian Gaviola is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 16 Similar Profiles
Students Medicine & Life Sciences
Clostridium Infections Medicine & Life Sciences
Hydroxymethylglutaryl-CoA Reductase Inhibitors Medicine & Life Sciences
Surgical Wound Infection Medicine & Life Sciences
Spinal Fusion Medicine & Life Sciences
Clostridium difficile Medicine & Life Sciences
Megestrol Medicine & Life Sciences
Disclosure Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2016 2019

  • 13 Citations
  • 1 h-Index
  • 4 Article
  • 1 Review article
Students
Pharmacy Education
Random Allocation
Education
Feedback

Efficacy and Safety of Appetite-Stimulating Medications in the Inpatient Setting

Howard, M., Hossaini, R., Tolar, C. & Gaviola, M. L., 1 Mar 2019, In : Annals of Pharmacotherapy. 53, 3, p. 261-267 7 p.

Research output: Contribution to journalArticle

Megestrol
Appetite
Inpatients
Dronabinol
Meals

Statin Effects on Incidence, Treatment Success, and Mortality of Clostridium difficile Infections

Gaviola, M. L., Scribe, E. C., Leverett, H. N. & Howard, M., 1 Jan 2019, In : Journal of Pharmacy Practice.

Research output: Contribution to journalReview article

Clostridium Infections
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Clostridium difficile
Mortality
Incidence
Disclosure
Students
Patient Care
Pharmacists
Therapeutics
13 Citations (Scopus)

A Retrospective Study on the Protective Effects of Topical Vancomycin in Patients Undergoing Multilevel Spinal Fusion

Gaviola, M. L., McMillian, W. D., Ames, S. E., Endicott, J. A. & Alston, W. K., 1 Jan 2016, In : Pharmacotherapy. 36, 1, p. 19-25 7 p.

Research output: Contribution to journalArticle

Surgical Wound Infection
Spinal Fusion
Vancomycin
Cefazolin
Retrospective Studies